These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31751393)

  • 21. HCV genotypes and age distribution in patients of Vienna and surrounding areas.
    Haushofer AC; Kopty C; Hauer R; Brunner H; Halbmayer WM
    J Clin Virol; 2001 Jan; 20(1-2):41-7. PubMed ID: 11163582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Regional differences in hospitalisations for complications of chronic hepatitis C in 2012].
    Rotily M; Abergel A; Branchoux S; Akremi R; de Léotoing L; Vainchtock A; Gaudin AF
    Sante Publique; 2017 Apr; 29(2):215-227. PubMed ID: 28737341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?
    Gountas I; Sypsa V; Anagnostou O; Martin N; Vickerman P; Kafetzopoulos E; Hatzakis A
    Addiction; 2017 Jul; 112(7):1290-1299. PubMed ID: 28107585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic hepatitis C: etiology, pathogenesis, treatment].
    Maev IV; Polunina TE; Polunina EV
    Klin Med (Mosk); 2009; 87(11):12-7. PubMed ID: 20143559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries.
    Younossi Z; Brown A; Buti M; Fagiuoli S; Mauss S; Rosenberg W; Serfaty L; Srivastava A; Smith N; Stepanova M; Beckerman R
    J Viral Hepat; 2016 Mar; 23(3):217-26. PubMed ID: 26482680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
    Mavrogiannaki A; Karamanos B; Manesis EK; Papatheodoridis GV; Koskinas J; Archimandritis AJ
    J Viral Hepat; 2009 Jun; 16(6):430-6. PubMed ID: 19200136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.
    Adinolfi LE; Restivo L; Zampino R; Guerrera B; Lonardo A; Ruggiero L; Riello F; Loria P; Florio A
    Atherosclerosis; 2012 Apr; 221(2):496-502. PubMed ID: 22385985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
    Ladero JM; Torrejón MJ; Sánchez-Pobre P; Suárez A; Cuenca F; de la Orden V; Devesa MJ; Rodrigo M; Estrada V; López-Alonso G; Agúndez JA
    Ann Hepatol; 2013; 12(2):199-204. PubMed ID: 23396730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hepatitis C: genotypes 4 to 9.
    Nguyen MH; Keeffe EB
    Clin Liver Dis; 2005 Aug; 9(3):411-26, vi. PubMed ID: 16023974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between chronic hepatitis C infection and cardiovascular risk.
    Pateria P; Jeffrey GP; MacQuillan G; Speers D; Ching H; Chinnaratha MA; Watts GF; Adams LA
    Intern Med J; 2016 Jan; 46(1):63-70. PubMed ID: 26477784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.
    Neukam K; Nattermann J; Rallón N; Rivero A; Caruz A; Macías J; Vogel M; Benito J; Camacho A; Mira J; Schwarze-Zander C; Barreiro P; Martínez A; Rockstroh J; Soriano V; Pineda J
    HIV Med; 2011 Sep; 12(8):487-93. PubMed ID: 21375685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting.
    Senn O; Seidenberg A; Rosemann T
    Addiction; 2009 Dec; 104(12):2033-8. PubMed ID: 19922570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicentre, observational study on demographic and disease characteristics of patients seeking care for chronic hepatitis C in Belgium in 2016.
    Bourgeois S; Mulkay JP; Lasser L; Robaeys G; Bastens B; Delwaide J; Pollet S; Van den Enden M
    Acta Gastroenterol Belg; 2019; 82(1):43-52. PubMed ID: 30888753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.
    Ward JW
    Clin Liver Dis; 2013 Feb; 17(1):1-11. PubMed ID: 23177279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings.
    Dore GJ; Freeman AJ; Law M; Kaldor JM
    Antivir Ther; 2003 Oct; 8(5):365-72. PubMed ID: 14640382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C.
    D'Aliberti D; Cacciola I; Musolino C; Raffa G; Filomia R; Alibrandi A; Benfatto S; Beninati C; Saitta C; Giosa D; Romeo O; Raimondo G; Pollicino T
    Intervirology; 2018; 61(1):1-8. PubMed ID: 30021203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
    Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
    Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low Prevalence of Insulin Resistance Among Iranian Patients with Chronic Hepatitis C Virus Infection: A Case-Control Study.
    Eshraghian K; Lankarani KB; Fattahi MR; Esmailnejad A; Peymani P
    Curr Diabetes Rev; 2018; 14(5):446-450. PubMed ID: 28714382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.